Literature DB >> 9755930

E-test for susceptibility testing of Mycobacterium tuberculosis.

J Hausdorfer1, E Sompek, F Allerberger, M P Dierich, S Rüsch-Gerdes.   

Abstract

SETTING: Initial isolates should be tested for drug susceptibility to confirm the anticipated effectiveness of chemotherapy.
OBJECTIVE: To evaluate E-test strips for susceptibility testing of Mycobacterium tuberculosis.
DESIGN: A proportion method using Lowenstein-Jensen medium and the Bactec radiometric system were compared with the E-test (isoniazid [INH], rifampicin [RMP], ethambutol [EMB] and streptomycin [SM]).
RESULTS: For 73 of the 81 M. tuberculosis isolates (90.1%) the proportion and E-test methods yielded concordant susceptibility results against all four antimicrobial agents tested. Of these 73 strains, 69 were fully susceptible; the four isolates showing resistance to antimicrobial drugs by both methods were also resistant when tested by Bactec 460TB. While the proportion method indicated susceptibility for the eight remaining strains, E-test results showed mono EMB resistance in five strains, INH resistance for two isolates (including one isolate resistant to EMB plus INH), and for one strain E-test yielded resistance to EMB and SM. Using Bactec as the reference method, the E-test resulted in false resistance in eight strains and no false susceptibility.
CONCLUSION: Due to a substantial rate of false resistance, this method cannot be recommended at present for practical use in clinical laboratories.

Entities:  

Mesh:

Year:  1998        PMID: 9755930

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  9 in total

1.  Usefulness of E-test strips for testing susceptibility of Mycobacterium tuberculosis complex strains.

Authors:  J Esteban; A Ortiz; M S Jiménez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

2.  Evaluation of Etest for susceptibility testing of multidrug-resistant isolates of Mycobacterium tuberculosis.

Authors:  M H Hazbón; M del Socorro Orozco; L A Labrada; R Tovar; K A Weigle; A Wanger
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

3.  Evaluation of Etest strips for rapid susceptibility testing of Mycobacterium tuberculosis.

Authors:  I M Freixo; P C S Caldas; F Martins; R C Brito; R M C Ferreira; L S Fonseca; M H F Saad
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

Review 4.  The Age of Next-Generation Therapeutic-Microbe Discovery: Exploiting Microbe-Microbe and Host-Microbe Interactions for Disease Prevention.

Authors:  Nathan Cruz; George A Abernathy; Armand E K Dichosa; Anand Kumar
Journal:  Infect Immun       Date:  2022-04-06       Impact factor: 3.609

5.  Comparative study for determination of Mycobacterium tuberculosis susceptibility to first- and second-line antituberculosis drugs by the Etest using 7H11, blood, and chocolate agar.

Authors:  Ahmet Yilmaz Coban; Kemal Bilgin; Meltem Uzun; Alper Akgunes; Anne Yusof; Belma Durupinar
Journal:  J Clin Microbiol       Date:  2008-10-22       Impact factor: 5.948

Review 6.  Methods for in vitro evaluating antimicrobial activity: A review.

Authors:  Mounyr Balouiri; Moulay Sadiki; Saad Koraichi Ibnsouda
Journal:  J Pharm Anal       Date:  2015-12-02

7.  Green Chemistry Based Gold Nanoparticles Synthesis Using the Marine Bacterium Lysinibacillus odysseyi PBCW2 and Their Multitudinous Activities.

Authors:  Tijo Cherian; Debasis Maity; Ramasamy T Rajendra Kumar; Govindasamy Balasubramani; Chinnasamy Ragavendran; Suneelkumar Yalla; Raju Mohanraju; Willie J G M Peijnenburg
Journal:  Nanomaterials (Basel)       Date:  2022-08-26       Impact factor: 5.719

8.  Frequency of Uropathogens and Antimicrobial Susceptibility in Childhood Urinary Tract Infection at Kamenge University Hospital, Bujumbura, Burundi.

Authors:  Joseph Nyandwi; Sébastien Manirakiza; Eugàne Ndirahisha; Jean Baptiste Ngomirakiza; Désiré Nisubire; Emmanuel Nduwayo; Hélàne Bukuru
Journal:  East Afr Health Res J       Date:  2017-03-01

Review 9.  Evolution of Antibacterial Drug Screening Methods: Current Prospects for Mycobacteria.

Authors:  Clara M Bento; Maria Salomé Gomes; Tânia Silva
Journal:  Microorganisms       Date:  2021-12-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.